Bruno Stricker

Bruno Stricker is a Researcher in the Department of Epidemiology at Erasmus University Medical Center, Erasmus University Rotterdam. With over 780 research outputs spanning decades, his work focuses on pharmacoepidemiology, genetic epidemiology, and aging-related health outcomes through major cohort studies like the Rotterdam Study.

His primary research domains include:

• Epidemiology (cohort studies, hazard ratios, odds ratios)
• Pharmacology (anticholinergic drugs, antihypertensives, drug safety)
• Genetics (SNPs, genetic divergence, diabetes)
• Geriatrics (fall risk, multimorbidity, vascular aging)
• Cardiovascular Disease (atrial fibrillation, vascular dysfunction)

Recent publications reveal strong trends in medication risk assessment for elderly populations, particularly examining anticholinergic burden interactions with depression and vascular health biomarkers. His work consistently leverages longitudinal data from the Rotterdam Study to validate prediction models for mortality and disease progression in aging cohorts.

No scientific awards were documented in the available information.

Dr. Stricker has supervised 55 students according to institutional records, demonstrating significant academic mentorship in epidemiological methods and chronic disease research. His work shows consistent collaboration with researchers across pharmacology, cardiology, and geriatrics disciplines.

His research is fundamentally integrated with the Rotterdam Study, a landmark prospective population-based cohort investigating chronic disease determinants in aging populations. This infrastructure supports his investigations into drug-disease interactions, genetic risk factors, and multimorbidity prediction models.